Human medicines European public assessment report (EPAR): Rezdiffra, resmetirom, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

27 May 2026

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 23, Status: Authorised

27 May 2026

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 15, Status: Authorised

27 May 2026

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

27 May 2026

One Health approach

26 May 2026

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 52, Status: Authorised

26 May 2026

Human medicines European public assessment report (EPAR): Avonex, interferon beta-1a, Date of authorisation: 13/03/1997, Revision: 41, Status: Authorised

26 May 2026

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

26 May 2026

Medicinal products for human use: monthly figures - April 2026

26 May 2026

Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised

26 May 2026